Stone Warren bought NEO

February 23, 2024 · Form 4 insider transaction

Stone Warren bought 25,330 shares of NeoGenomics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.

Direction
Acquired (buy-side)
Shares
25,330
Price
$0.00
Total value
N/A
Role—
SecurityPerformance Stock Unit
Transaction codeA: Grant or award
Transaction dateFebruary 23, 2024
Filing dateFebruary 27, 2024
Shares owned after25,330
OwnershipDirect
10b5-1 planNo
AmendedNo

Footnotes

On February 23, 2024, Mr. Stone was granted 25,330 performance stock units representing the number of shares that may vest at target performance. The maximum number of shares that may vest pursuant to the performance criteria is 37,996. 50% of the number of performance stock units that may vest is based on the achievements of certain share growth goals based on the weighted average price of the Company's common stock over the 20-day trailing trading period at the applicable measurement dates, subject to continued service with the Company. 50% of the number of performance stock units that may vest is based on the achievement of certain revenue growth goals based on the achievement of the cumulative fiscal year revenue goal at the applicable measurement amounts, subject to continued service with the Company.; Once vested, the shares of common stock are not subject to expiration.

View the original Form 4 on SEC EDGAR